Patents Assigned to Novalar Pharmaceuticals, Inc.
-
Patent number: 7575757Abstract: The present invention provides compositions and stable liquid formulations comprising alpha adrenergic receptor antagonists and use thereof for increasing blood flow. In one embodiment, the stable liquid formulations of this invention are useful for reversing the effects of an anesthetic agent, preferably a long-lasting local anesthetic agent administered in conjunction with an alpha adrenergic receptor agonist.Type: GrantFiled: March 18, 2005Date of Patent: August 18, 2009Assignee: Novalar Pharmaceuticals, Inc.Inventors: Andrew X. Chen, Julius Knowles, Eckard Weber
-
Patent number: 7569230Abstract: The present invention provides compositions and stable liquid formulations comprising alpha adrenergic receptor antagonists and use thereof for increasing blood flow. In one embodiment, the stable liquid formulations of this invention are useful for reversing the effects of an anesthetic agent, preferably a long-lasting local anesthetic agent administered in conjunction with an alpha adrenergic receptor agonist.Type: GrantFiled: December 15, 2006Date of Patent: August 4, 2009Assignee: Novalar Pharmaceuticals, Inc.Inventors: Andrew X Chen, Julius Knowles, Eckard Weber
-
Publication number: 20090076023Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: ApplicationFiled: November 21, 2008Publication date: March 19, 2009Applicant: Novalar Pharmaceuticals, Inc.Inventors: Eckard WEBER, Howard I. Katz
-
Patent number: 7331787Abstract: Endodontic fibers comprising a biocompatible polymer vehicle permeable to medicaments, or combinations of medicaments are described. Such fibers can be used, for example, in a method for the local delivery and sustained release of medicaments to periodontal or intracanal treatment sites. Endodontic fibers described include modified periodontal fibers and intracanal fibers.Type: GrantFiled: March 29, 2004Date of Patent: February 19, 2008Assignee: Novalar Pharmaceuticals, Inc.Inventors: Mario Abdennour, Philip Stashenko, Michele Scrime, Jack Gilad, Max Goodson
-
Patent number: 7261889Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: GrantFiled: March 17, 2005Date of Patent: August 28, 2007Assignee: Novalar Pharmaceuticals, Inc.Inventors: Eckard Weber, Howard I. Katz
-
Patent number: 7229630Abstract: The present invention provides compositions and stable liquid formulations comprising alpha adrenergic receptor antagonists and use thereof for increasing blood flow. In one embodiment, the stable liquid formulations of this invention are useful for reversing the effects of an anesthetic agent, preferably a long-lasting local anesthetic agent administered in conjunction with an alpha adrenergic receptor agonist.Type: GrantFiled: June 20, 2003Date of Patent: June 12, 2007Assignee: Novalar Pharmaceuticals, Inc.Inventors: Andrew X. Chen, Julius Knowles, Eckard Weber
-
Patent number: 6872390Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: GrantFiled: May 28, 2002Date of Patent: March 29, 2005Assignee: Novalar Pharmaceuticals, Inc.Inventors: Eckard Weber, Howard I. Katz
-
Publication number: 20040198816Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: ApplicationFiled: April 5, 2004Publication date: October 7, 2004Applicant: Novalar Pharmaceuticals, Inc.Inventors: Eckard Weber, Howard I. Katz
-
Patent number: 6764678Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: GrantFiled: May 28, 2002Date of Patent: July 20, 2004Assignee: Novalar Pharmaceuticals, Inc.Inventors: Eckard Weber, Howard I. Katz
-
Publication number: 20020183396Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: ApplicationFiled: May 28, 2002Publication date: December 5, 2002Applicant: Novalar Pharmaceuticals, Inc.Inventors: Eckard Weber, Howard I. Katz
-
Publication number: 20020183356Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: ApplicationFiled: May 28, 2002Publication date: December 5, 2002Applicant: Novalar Pharmaceuticals, Inc.Inventors: Eckard Weber, Howard I Katz
-
Patent number: 6432401Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: GrantFiled: May 11, 2001Date of Patent: August 13, 2002Assignee: Novalar Pharmaceuticals, Inc.Inventors: Eckard Weber, Howard I. Katz
-
Publication number: 20010056125Abstract: Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist. Also disclosed are kits comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist.Type: ApplicationFiled: May 11, 2001Publication date: December 27, 2001Applicant: Novalar Pharmaceuticals, Inc.Inventors: Eckard Weber, Howard I. Katz